Abstract
Post-graft hematopoiesis is characterized by long-term quantitative deficiency in marrow progenitor cells in both autologous and allogenic settings. In order to evaluate the function of post-graft progenitor cells, the proliferative capacity of marrow CD34+ cells was evaluated in 10 patients 6 months after autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma and compared to that of 10 patients before ABMT and 10 normal controls. Immuno-selected CD34+ cells were cultured for 7 days in liquid serum-free medium with a combination of early-acting GF consisting of stem cell factor, IL-3 and IL-1β. Clonogenic efficiency of unselected cells for CFU-GM and BFU-E was decreased in post-graft patients compared to pre-graft and control patients. However, clonogenic efficiency of selected CD34+ cells for CFU-GM was not different in post-graft, pre-graft and control patients but BFU-E values of post-graft patients remained lower than those of control patients. Decreased percentages of CD34+ CD38− cells were observed in both post-graft and pre-graft patients while those of CD34+ c-kit+ cells were similar in all three patient groups. After 7-day liquid culture, expansion yields of total progenitor cells were significantly lower in post-graft patients (147 ± 28%) than in pre-graft (255 ± 27%) and control patients (246 ± 23%). Post-graft deficiency in progenitor cell expansion was particularly marked for BFU-E (61 ± 24%) compared to pre-graft patients (220 ± 82%) and to controls (349 ± 82%). These results indicate impaired proliferative potential of marrow CD34+ cells several months after ABMT involving erythroid progenitor cells and/or commitment towards erythroid lineage from a more immature stage (pre-CFU).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Szilvassy SJ, Fraser CC, Eaves CJ et al. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability Proc Natl Acad Sci USA 1989 86: 8798 8802
Wolf NS, Kone A, Priestley GV, Bartelmez SH . In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342–rhodamine 123 FACS selection Exp Hematol 1993 21: 614 622
Messner HA, Curtis JE, Minden MD et al. Clonogenic hemopoietic precursors in bone marrow transplantation Blood 1987 70: 1425 1432
Domenech J, Linassier C, Gihana E et al. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation Blood 1995 85: 3320 3327
Darrington DL, Vose JM, Anderson JR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 1994 12: 2527 2534
Friedberg JW, Neuberg D, Stone RM et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1999 17: 3128 3135
Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy (see comments) Blood 1994 83: 3780 3786
Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1994 12: 2535 2542
Herault O, Binet C, Degenne M et al. In vitro effect of stem cell factor on human clonogenic marrow progenitors after myeloablative treatments Eur J Haematol 1998 61: 113 118
Dexter TM, Allen TD, Lajtha LG . Conditions controlling the proliferation of haemopoietic stem cells in vitro J Cell Physiol 1977 91: 335 344
Domenech J, Gihana E, Dayan A et al. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture Br J Haematol 1994 88: 488 496
Cartron G, Herault O, Benboubker L et al. Quantitative and qualitative analysis of the human primitive progenitor cell compartment after autologous stem cell transplantation J Hematother Stem Cell Res 2002 (in press)
Lebkowski JS, Schain LR, Okrongly D et al. Rapid isolation of human CD34 hematopoietic stem cells – purging of human tumor cells Transplantation 1992 53: 1011 1019
Haas R, Witt B, Mohle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support Blood 1995 85: 3754 3761
Novitzky N, Mohammed R . Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation Exp Hematol 1997 25: 471 477
Rusten LS, Jacobsen SE, Kaalhus O et al. Functional differences between CD38− and DR− subfractions of CD34+ bone marrow cells Blood 1994 84: 1473 1481
Terstappen LW, Huang S, Safford M et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38− progenitor cells Blood 1991 77: 1218 1227
Neben S, Hellman S . Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents Exp Hematol 1993 21: 156 162
Robinson SN, Freedman AS, Neuberg DS et al. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(−), and week-6 CAFC assays predict poor engraftment Exp Hematol 2000 28: 1325 1333
Soligo DA, Lambertenghi Deliliers G, Servida F et al. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients Bone Marrow Transplant 1998 21: 15 22
Voso MT, Murea S, Goldschmidt H et al. High-dose therapy with peripheral blood stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment Br J Haematol 1996 94: 759 766
Podesta M, Piaggio G, Frassoni F et al. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 1011 1017
Selleri C, Maciejewski JP, De Rosa G et al. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant Bone Marrow Transplant 1999 23: 1029 1037
Novitzky N, Mohamed R . Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation Exp Hematol 1995 23: 1661 1666
Hellman S, Botnick LE, Hannon EC, Vigneulle RM . Proliferative capacity of murine hematopoietic stem cells Proc Natl Acad Sci USA 1978 75: 490 494
Mauch P, Botnick LE, Hannon EC et al. Decline in bone marrow proliferative capacity as a function of age Blood 1982 60: 245 252
Mauch P, Hellman S . Loss of hematopoietic stem cell self-renewal after bone marrow transplantation Blood 1989 74: 872 875
Lansdorp PM, Dragowska W, Mayani H . Ontogeny-related changes in proliferative potential of human hematopoietic cells J Exp Med 1993 178: 787 791
Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc Natl Acad Sci USA 1994 91: 9857 9860
Wynn RF, Cross MA, Hatton C et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants Lancet 1998 351: 178 181
Akiyama M, Asai O, Kuraishi Y et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 2000 25: 441 447
Domenech J, Roingeard F, Herault O et al. Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation Leuk Lymphoma 1998 29: 533 546
Roingeard F, Binet C, Lecron JC et al. Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy Eur J Haematol 1998 61: 100 108
Galotto M, Berisso G, Delfino L et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Exp Hematol 1999 27: 1460 1466
Grande T, Bueren JA . Involvement of the bone marrow stroma in the residual hematopoietic damage induced by irradiation of adult and young mice Exp Hematol 1994 22: 1283 1287
Acknowledgements
The authors wish to thank Professors M Marchand and M Aupart for kindly providing normal bone marrow samples. This study was supported by grants from the Ministère de la Recherche No. 995101061R1 and from Amgen-France.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Domenech, J., Cartron, G., Clement, N. et al. Persistent decrease in proliferative potential of marrow CD34+cells exposed to early-acting growth factors after autologous bone marrow transplantation. Bone Marrow Transplant 29, 557–562 (2002). https://doi.org/10.1038/sj.bmt.1703512
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703512
Keywords
This article is cited by
-
How Will the Hematopoietic System Deal with Space Radiation on the Way to Mars?
Current Stem Cell Reports (2017)